What Researchers Did
Researchers conducted a systematic review of six systematic reviews to evaluate the existing evidence, methodological quality, and evidence grade for osteoradionecrosis (ORN) treatment in adults with head and neck cancer.
What They Found
Six systematic reviews revealed critically low- or moderate-quality evidence that hyperbaric oxygen therapy (HBO) improves ORN healing, primarily based on studies from the 1990s. Pentoxifylline and tocopherol (PENTO) appears promising, particularly for mild and moderate stages of ORN, but the quality of evidence for PENTO, surgery, and other treatments remains critically low.
What This Means for Canadian Patients
Patients with head and neck cancer experiencing ORN may find that treatment options like pentoxifylline and tocopherol (PENTO) are considered promising, especially for milder cases. However, the current evidence for all treatments, including PENTO, is still critically low, meaning there is no universally established best approach.
Canadian Relevance
This systematic review does not have a direct Canadian connection.
Study Limitations
A major limitation is the critically low quality of evidence for most osteoradionecrosis treatments, including pentoxifylline and tocopherol, highlighting the need for more robust clinical studies.